Aion Therapeutic Inc.
ANTCF
$0.0055
$0.000.00%
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 198.20K | 161.50K | 124.10K | 137.10K | 137.50K |
| Depreciation & Amortization | -- | -- | 100.00 | 4.30K | 4.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 198.20K | 161.50K | 124.20K | 141.50K | 141.80K |
| Operating Income | -198.20K | -161.50K | -124.20K | -141.50K | -141.80K |
| Income Before Tax | -133.60K | -191.10K | -534.10K | -160.00K | -94.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -133.60K | -191.10K | -534.10K | -160.00K | -94.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -133.60K | -191.10K | -534.10K | -160.00K | -94.40K |
| EBIT | -198.20K | -161.50K | -124.20K | -141.50K | -141.80K |
| EBITDA | -- | -- | -124.10K | -137.10K | -137.50K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 190.32M | 168.81M | 147.27M | 147.30M | 147.30M |
| Average Diluted Shares Outstanding | 190.32M | 168.81M | 147.27M | 147.30M | 147.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
